Suchergebnisse - "Harkavyi, A"

PubPharm (3)

1

Neuroprotection by Exendin-4 Is GLP-1 Receptor Specific but DA D3 Receptor Dependent, Causing Altered BrdU Incorporation in Subventricular Zone and Substantia Nigra

enthalten in: Journal of neurodegenerative diseases | 2013

von Harkavyi, A. | Rampersaud, N. | Whitton, P.

2

Exendin-4 reverts behavioural and neurochemical dysfunction in a pre-motor rodent model of Parkinson's disease with noradrenergic deficit

enthalten in: British journal of pharmacology | 2012

von Rampersaud, N. | Harkavyi, A. | Giordano, G. | +3

RetractionIn: Br J Pharmacol. 2013 Jun;169(3):717. - PMID 23821776

3

Exendin-4 reverses biochemical and behavioral deficits in a pre-motor rodent model of Parkinson's disease with combined noradrenergic and serotonergic lesions

enthalten in: Neuropeptides | 2012

von Rampersaud, N. | Harkavyi, A. | Giordano, G. | +3

RetractionIn: Neuropeptides. 2013 Jun;47(3):221. - PMID 23866374

1
[1]